205 related articles for article (PubMed ID: 37386438)
1. Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study.
Vold JH; Halmøy A; Chalabianloo F; Pierron MC; Løberg EM; Johansson KA; Fadnes LT
BMC Psychiatry; 2023 Jun; 23(1):479. PubMed ID: 37386438
[TBL] [Abstract][Full Text] [Related]
2. Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017.
Vold JH; Aas C; Skurtveit S; Odsbu I; Chalabianloo F; Halmøy A; Johansson KA; Fadnes LT
BMC Psychiatry; 2020 Mar; 20(1):119. PubMed ID: 32164615
[TBL] [Abstract][Full Text] [Related]
3. Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment.
Fiksdal Abel K; Ravndal E; Clausen T; Bramness JG
Eur Addict Res; 2017; 23(6):298-305. PubMed ID: 29320768
[TBL] [Abstract][Full Text] [Related]
4. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.
van de Glind G; van den Brink W; Koeter MW; Carpentier PJ; van Emmerik-van Oortmerssen K; Kaye S; Skutle A; Bu ET; Franck J; Konstenius M; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Barta C; Schoevers RA; ; Levin FR
Drug Alcohol Depend; 2013 Oct; 132(3):587-96. PubMed ID: 23660242
[TBL] [Abstract][Full Text] [Related]
5. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
[TBL] [Abstract][Full Text] [Related]
6. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
[TBL] [Abstract][Full Text] [Related]
7. Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men.
Vogel T; Dom G; van de Glind G; Studer J; Gmel G; Strik W; Moggi F
Addiction; 2016 Oct; 111(10):1867-78. PubMed ID: 27061514
[TBL] [Abstract][Full Text] [Related]
8. Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents.
Adler LA; Shaw DM; Spencer TJ; Newcorn JH; Hammerness P; Sitt DJ; Minerly C; Davidow JV; Faraone SV
J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):238-44. PubMed ID: 22537184
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of ADHD in a Sample of Heroin Addicts Receiving Agonist Treatment-Study Conducted in a Public Addiction Service.
Rocco P
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767966
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the reliability and preliminary validity of the Adult ADHD Self-Report Scale v1.1 (ASRS v1.1) Screener in an adolescent community sample.
Green JG; DeYoung G; Wogan ME; Wolf EJ; Lane KL; Adler LA
Int J Methods Psychiatr Res; 2019 Mar; 28(1):e1751. PubMed ID: 30407687
[TBL] [Abstract][Full Text] [Related]
11. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
[TBL] [Abstract][Full Text] [Related]
12. Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis.
Ahlers J; Baumgartner C; Augsburger M; Wenger A; Malischnig D; Boumparis N; Berger T; Stark L; Ebert DD; Haug S; Schaub MP
J Med Internet Res; 2022 Apr; 24(4):e30138. PubMed ID: 35442196
[TBL] [Abstract][Full Text] [Related]
13. Validity and accuracy of the Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Self-Report Scale (ASRS) and the Wender Utah Rating Scale (WURS) symptom checklists in discriminating between adults with and without ADHD.
Brevik EJ; Lundervold AJ; Haavik J; Posserud MB
Brain Behav; 2020 Jun; 10(6):e01605. PubMed ID: 32285644
[TBL] [Abstract][Full Text] [Related]
14. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
[TBL] [Abstract][Full Text] [Related]
15. How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale.
Silverstein MJ; Faraone SV; Alperin S; Biederman J; Spencer TJ; Adler LA
J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):339-349. PubMed ID: 29172673
[TBL] [Abstract][Full Text] [Related]
16. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
Kolla NJ; van der Maas M; Toplak ME; Erickson PG; Mann RE; Seeley J; Vingilis E
BMC Psychiatry; 2016 Feb; 16():50. PubMed ID: 26920911
[TBL] [Abstract][Full Text] [Related]
17. A pilot study: Use of the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale in a South African patient population.
Regnart J; Truter I; Zingela Z; Meyer A
S Afr J Psychiatr; 2019; 25():1326. PubMed ID: 31205781
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
Coetzee C; Truter I; Meyer A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1271-1280. PubMed ID: 33040639
[TBL] [Abstract][Full Text] [Related]
19. Clinical Utility of the Korean Version of the WHO Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale Screener.
Heo S; Kim JH; Joung YS; Lee WI; Kim JJ; Sohn SH; Chang SA
Psychiatry Investig; 2018 Mar; 15(3):325-329. PubMed ID: 29486543
[TBL] [Abstract][Full Text] [Related]
20. A Cross-sectional Cohort Study of Prevalence, Co-Morbidities, and Correlates of Attention-deficit Hyperactivity Disorder among Adult Patients Admitted to the Li Ka Shing Psychiatric Outpatient Clinic, Hong Kong.
Leung VM; Chan LF
East Asian Arch Psychiatry; 2017 Jun; 27(2):63-70. PubMed ID: 28652499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
